Heterogenous nature of gene expression patterns in BRAF-like papillary thyroid carcinomas with BRAFV600E View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-09-02

AUTHORS

Yuji Nagayama, Hiroyuki Mishima

ABSTRACT

PurposePapillary thyroid cancers (PTCs) are the most common type of thyroid cancers, in which BRAFV600E is the most prevalent driver mutation. It is known that BRAFV600E-positive PTCs are clinically and molecularly heterogenous in terms of aggressiveness and prognosis. The molecular mechanisms of this heterogeneity were evaluated.MethodsThe publicly available RNA-seq data for 26 classical (c) and 5 follicular variant (fv) PTCs with BRAFV600E mutation and the BRAF-like expression signature in the BRAFV600E-RAS score (BRS) and their respective normal adjacent tissues were downloaded, and analyzed for differentially expressed genes (DEGs). The DEGs were then analyzed with the Gene Ontology annotation and the KEGG pathway dataset.ResultsWe found four lines of evidence for heterogeneity of cPTCs. First, the cluster dendrogram and principle component analyses could not completely distinguish the cancer tissues from normal tissues. Second, the DEGs identified in each sample were highly diverse from one another. Third, although the DEGs were enriched in many terms containing the word “extracellular” (“extracellular region”, “extracellular space”, and so on) when analyzed as groups, the degree of this enrichment was variable when analyzed individually. Fourth, there are only a few intersections in the over-/underexpressed genes annotated with the terms containing the word “extracellular” among the samples examined. Essentially same results were obtained with BRAF-like, fvPTCs with BRAFV600E. Nevertheless, some frequently over-/underexpressed genes were detected, of which LIPH (lipase H) expression was found to be prognostic and its high expression was favorable for PTCs.ConclusionGroups of BRAF-like, BRAFV600E-positive cPTCs and fvPTCs that are homogenous in regard to histopathology, driver mutation and BRS were found to be highly heterogenous in terms of gene expression patterns. Yet, among the genes that were annotated with the terms containing the word “extracellular” and frequently over-/underexpressed, LIPH is a favorable prognostic marker for PTCs. More... »

PAGES

607-613

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12020-019-02063-z

DOI

http://dx.doi.org/10.1007/s12020-019-02063-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1120766076

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/31478162


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1114", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Paediatrics and Reproductive Medicine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Principal Component Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins B-raf", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thyroid Cancer, Papillary", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thyroid Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan", 
          "id": "http://www.grid.ac/institutes/grid.174567.6", 
          "name": [
            "Department of Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nagayama", 
        "givenName": "Yuji", 
        "id": "sg:person.0614673051.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614673051.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Human Genetics, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan", 
          "id": "http://www.grid.ac/institutes/grid.174567.6", 
          "name": [
            "Department of Human Genetics, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mishima", 
        "givenName": "Hiroyuki", 
        "id": "sg:person.0643355356.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643355356.48"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10238-016-0445-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053060417", 
          "https://doi.org/10.1007/s10238-016-0445-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nmeth.3317", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005140994", 
          "https://doi.org/10.1038/nmeth.3317"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13277-015-3985-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025762225", 
          "https://doi.org/10.1007/s13277-015-3985-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41598-018-28299-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1105156492", 
          "https://doi.org/10.1038/s41598-018-28299-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13046-016-0447-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039054821", 
          "https://doi.org/10.1186/s13046-016-0447-3"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-09-02", 
    "datePublishedReg": "2019-09-02", 
    "description": "PurposePapillary thyroid cancers (PTCs) are the most common type of thyroid cancers, in which BRAFV600E is the most prevalent driver mutation. It is known that BRAFV600E-positive PTCs are clinically and molecularly heterogenous in terms of aggressiveness and prognosis. The molecular mechanisms of this heterogeneity were evaluated.MethodsThe publicly available RNA-seq data for 26 classical (c) and 5 follicular variant (fv) PTCs with BRAFV600E mutation and the BRAF-like expression signature in the BRAFV600E-RAS score (BRS) and their respective normal adjacent tissues were downloaded, and analyzed for differentially expressed genes (DEGs). The DEGs were then analyzed with the Gene Ontology annotation and the KEGG pathway dataset.ResultsWe found four lines of evidence for heterogeneity of cPTCs. First, the cluster dendrogram and principle component analyses could not completely distinguish the cancer tissues from normal tissues. Second, the DEGs identified in each sample were highly diverse from one another. Third, although the DEGs were enriched in many terms containing the word \u201cextracellular\u201d (\u201cextracellular region\u201d, \u201cextracellular space\u201d, and so on) when analyzed as groups, the degree of this enrichment was variable when analyzed individually. Fourth, there are only a few intersections in the over-/underexpressed genes annotated with the terms containing the word \u201cextracellular\u201d among the samples examined. Essentially same results were obtained with BRAF-like, fvPTCs with BRAFV600E. Nevertheless, some frequently over-/underexpressed genes were detected, of which LIPH (lipase H) expression was found to be prognostic and its high expression was favorable for PTCs.ConclusionGroups of BRAF-like, BRAFV600E-positive cPTCs and fvPTCs that are homogenous in regard to histopathology, driver mutation and BRS were found to be highly heterogenous in terms of gene expression patterns. Yet, among the genes that were annotated with the terms containing the word \u201cextracellular\u201d and frequently over-/underexpressed, LIPH is a favorable prognostic marker for PTCs.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12020-019-02063-z", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7534680", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.8439423", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1112251", 
        "issn": [
          "1355-008X", 
          "1559-0100"
        ], 
        "name": "Endocrine", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "66"
      }
    ], 
    "keywords": [
      "gene expression patterns", 
      "expression patterns", 
      "available RNA-seq data", 
      "Gene Ontology annotations", 
      "RNA-seq data", 
      "driver mutations", 
      "Ontology annotations", 
      "LIPH expression", 
      "molecular mechanisms", 
      "genes", 
      "lines of evidence", 
      "cluster dendrogram", 
      "expression signatures", 
      "normal adjacent tissues", 
      "pathway datasets", 
      "mutations", 
      "high expression", 
      "BRAF-like", 
      "terms of aggressiveness", 
      "cancer tissues", 
      "deg", 
      "expression", 
      "DEGs", 
      "normal tissues", 
      "tissue", 
      "LIPH", 
      "BRAFV600E", 
      "adjacent tissues", 
      "dendrogram", 
      "BRAFV600E.", 
      "annotation", 
      "ResultsWe", 
      "principle component analysis", 
      "cPTCs", 
      "patterns", 
      "heterogenous nature", 
      "thyroid cancer", 
      "BRAFV600E mutation", 
      "enrichment", 
      "favorable prognostic marker", 
      "heterogeneity", 
      "papillary thyroid carcinoma", 
      "markers", 
      "cancer", 
      "BRAF", 
      "mechanism", 
      "prognostic marker", 
      "lines", 
      "component analysis", 
      "aggressiveness", 
      "signatures", 
      "FVPTCs", 
      "thyroid carcinoma", 
      "ConclusionGroup", 
      "common type", 
      "evidence", 
      "analysis", 
      "types", 
      "dataset", 
      "samples", 
      "same results", 
      "data", 
      "nature", 
      "results", 
      "carcinoma", 
      "group", 
      "degree", 
      "regard", 
      "terms", 
      "MethodsThe", 
      "prognosis", 
      "histopathology", 
      "scores", 
      "intersection", 
      "words"
    ], 
    "name": "Heterogenous nature of gene expression patterns in BRAF-like papillary thyroid carcinomas with BRAFV600E", 
    "pagination": "607-613", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1120766076"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12020-019-02063-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "31478162"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12020-019-02063-z", 
      "https://app.dimensions.ai/details/publication/pub.1120766076"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_792.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12020-019-02063-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12020-019-02063-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12020-019-02063-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12020-019-02063-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12020-019-02063-z'


 

This table displays all metadata directly associated to this object as RDF triples.

198 TRIPLES      22 PREDICATES      113 URIs      99 LITERALS      13 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12020-019-02063-z schema:about N22e22735ef9144839c5fc94cb1b34218
2 N53592ab7be12475ba1ff8ebc46d8bbd2
3 N5c49310a830a412eab57f6916b552d44
4 N8f8f08d56ad4438e81cbeafb68f8eb55
5 Nc9b417beeb6044d8a91c5eb7797348d2
6 Ne98d90df7aa448f498a97ae7a6596622
7 anzsrc-for:11
8 anzsrc-for:1103
9 anzsrc-for:1114
10 schema:author N7e32bdfdcf76469c93ac6871ca1f6da7
11 schema:citation sg:pub.10.1007/s10238-016-0445-y
12 sg:pub.10.1007/s13277-015-3985-y
13 sg:pub.10.1038/nmeth.3317
14 sg:pub.10.1038/s41598-018-28299-9
15 sg:pub.10.1186/s13046-016-0447-3
16 schema:datePublished 2019-09-02
17 schema:datePublishedReg 2019-09-02
18 schema:description PurposePapillary thyroid cancers (PTCs) are the most common type of thyroid cancers, in which BRAFV600E is the most prevalent driver mutation. It is known that BRAFV600E-positive PTCs are clinically and molecularly heterogenous in terms of aggressiveness and prognosis. The molecular mechanisms of this heterogeneity were evaluated.MethodsThe publicly available RNA-seq data for 26 classical (c) and 5 follicular variant (fv) PTCs with BRAFV600E mutation and the BRAF-like expression signature in the BRAFV600E-RAS score (BRS) and their respective normal adjacent tissues were downloaded, and analyzed for differentially expressed genes (DEGs). The DEGs were then analyzed with the Gene Ontology annotation and the KEGG pathway dataset.ResultsWe found four lines of evidence for heterogeneity of cPTCs. First, the cluster dendrogram and principle component analyses could not completely distinguish the cancer tissues from normal tissues. Second, the DEGs identified in each sample were highly diverse from one another. Third, although the DEGs were enriched in many terms containing the word “extracellular” (“extracellular region”, “extracellular space”, and so on) when analyzed as groups, the degree of this enrichment was variable when analyzed individually. Fourth, there are only a few intersections in the over-/underexpressed genes annotated with the terms containing the word “extracellular” among the samples examined. Essentially same results were obtained with BRAF-like, fvPTCs with BRAFV600E. Nevertheless, some frequently over-/underexpressed genes were detected, of which LIPH (lipase H) expression was found to be prognostic and its high expression was favorable for PTCs.ConclusionGroups of BRAF-like, BRAFV600E-positive cPTCs and fvPTCs that are homogenous in regard to histopathology, driver mutation and BRS were found to be highly heterogenous in terms of gene expression patterns. Yet, among the genes that were annotated with the terms containing the word “extracellular” and frequently over-/underexpressed, LIPH is a favorable prognostic marker for PTCs.
19 schema:genre article
20 schema:inLanguage en
21 schema:isAccessibleForFree false
22 schema:isPartOf N6c1c6c8b92de45abb03f152f6ab3133b
23 Nc6d8399c02a54e1aaeced9cc7d7bb2e7
24 sg:journal.1112251
25 schema:keywords BRAF
26 BRAF-like
27 BRAFV600E
28 BRAFV600E mutation
29 BRAFV600E.
30 ConclusionGroup
31 DEGs
32 FVPTCs
33 Gene Ontology annotations
34 LIPH
35 LIPH expression
36 MethodsThe
37 Ontology annotations
38 RNA-seq data
39 ResultsWe
40 adjacent tissues
41 aggressiveness
42 analysis
43 annotation
44 available RNA-seq data
45 cPTCs
46 cancer
47 cancer tissues
48 carcinoma
49 cluster dendrogram
50 common type
51 component analysis
52 data
53 dataset
54 deg
55 degree
56 dendrogram
57 driver mutations
58 enrichment
59 evidence
60 expression
61 expression patterns
62 expression signatures
63 favorable prognostic marker
64 gene expression patterns
65 genes
66 group
67 heterogeneity
68 heterogenous nature
69 high expression
70 histopathology
71 intersection
72 lines
73 lines of evidence
74 markers
75 mechanism
76 molecular mechanisms
77 mutations
78 nature
79 normal adjacent tissues
80 normal tissues
81 papillary thyroid carcinoma
82 pathway datasets
83 patterns
84 principle component analysis
85 prognosis
86 prognostic marker
87 regard
88 results
89 same results
90 samples
91 scores
92 signatures
93 terms
94 terms of aggressiveness
95 thyroid cancer
96 thyroid carcinoma
97 tissue
98 types
99 words
100 schema:name Heterogenous nature of gene expression patterns in BRAF-like papillary thyroid carcinomas with BRAFV600E
101 schema:pagination 607-613
102 schema:productId N0960e4b1db054b3eadb2a6ba133d17d1
103 N6be2cea71591465ba5dd089911fe7086
104 Nbebfa759cc7149918beaaf3f0e26bc2e
105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1120766076
106 https://doi.org/10.1007/s12020-019-02063-z
107 schema:sdDatePublished 2022-05-20T07:35
108 schema:sdLicense https://scigraph.springernature.com/explorer/license/
109 schema:sdPublisher N48ee8722d3294a67be5c3393ff71926b
110 schema:url https://doi.org/10.1007/s12020-019-02063-z
111 sgo:license sg:explorer/license/
112 sgo:sdDataset articles
113 rdf:type schema:ScholarlyArticle
114 N0960e4b1db054b3eadb2a6ba133d17d1 schema:name dimensions_id
115 schema:value pub.1120766076
116 rdf:type schema:PropertyValue
117 N22e22735ef9144839c5fc94cb1b34218 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Humans
119 rdf:type schema:DefinedTerm
120 N48ee8722d3294a67be5c3393ff71926b schema:name Springer Nature - SN SciGraph project
121 rdf:type schema:Organization
122 N53592ab7be12475ba1ff8ebc46d8bbd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Proto-Oncogene Proteins B-raf
124 rdf:type schema:DefinedTerm
125 N5c49310a830a412eab57f6916b552d44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Thyroid Cancer, Papillary
127 rdf:type schema:DefinedTerm
128 N6be2cea71591465ba5dd089911fe7086 schema:name pubmed_id
129 schema:value 31478162
130 rdf:type schema:PropertyValue
131 N6c1c6c8b92de45abb03f152f6ab3133b schema:issueNumber 3
132 rdf:type schema:PublicationIssue
133 N7e32bdfdcf76469c93ac6871ca1f6da7 rdf:first sg:person.0614673051.45
134 rdf:rest Ned54c5d3eadc441b81cb2b5beec7615b
135 N8f8f08d56ad4438e81cbeafb68f8eb55 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Principal Component Analysis
137 rdf:type schema:DefinedTerm
138 Nbebfa759cc7149918beaaf3f0e26bc2e schema:name doi
139 schema:value 10.1007/s12020-019-02063-z
140 rdf:type schema:PropertyValue
141 Nc6d8399c02a54e1aaeced9cc7d7bb2e7 schema:volumeNumber 66
142 rdf:type schema:PublicationVolume
143 Nc9b417beeb6044d8a91c5eb7797348d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Thyroid Neoplasms
145 rdf:type schema:DefinedTerm
146 Ne98d90df7aa448f498a97ae7a6596622 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Gene Expression
148 rdf:type schema:DefinedTerm
149 Ned54c5d3eadc441b81cb2b5beec7615b rdf:first sg:person.0643355356.48
150 rdf:rest rdf:nil
151 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
152 schema:name Medical and Health Sciences
153 rdf:type schema:DefinedTerm
154 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
155 schema:name Clinical Sciences
156 rdf:type schema:DefinedTerm
157 anzsrc-for:1114 schema:inDefinedTermSet anzsrc-for:
158 schema:name Paediatrics and Reproductive Medicine
159 rdf:type schema:DefinedTerm
160 sg:grant.7534680 http://pending.schema.org/fundedItem sg:pub.10.1007/s12020-019-02063-z
161 rdf:type schema:MonetaryGrant
162 sg:grant.8439423 http://pending.schema.org/fundedItem sg:pub.10.1007/s12020-019-02063-z
163 rdf:type schema:MonetaryGrant
164 sg:journal.1112251 schema:issn 1355-008X
165 1559-0100
166 schema:name Endocrine
167 schema:publisher Springer Nature
168 rdf:type schema:Periodical
169 sg:person.0614673051.45 schema:affiliation grid-institutes:grid.174567.6
170 schema:familyName Nagayama
171 schema:givenName Yuji
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614673051.45
173 rdf:type schema:Person
174 sg:person.0643355356.48 schema:affiliation grid-institutes:grid.174567.6
175 schema:familyName Mishima
176 schema:givenName Hiroyuki
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643355356.48
178 rdf:type schema:Person
179 sg:pub.10.1007/s10238-016-0445-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1053060417
180 https://doi.org/10.1007/s10238-016-0445-y
181 rdf:type schema:CreativeWork
182 sg:pub.10.1007/s13277-015-3985-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1025762225
183 https://doi.org/10.1007/s13277-015-3985-y
184 rdf:type schema:CreativeWork
185 sg:pub.10.1038/nmeth.3317 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005140994
186 https://doi.org/10.1038/nmeth.3317
187 rdf:type schema:CreativeWork
188 sg:pub.10.1038/s41598-018-28299-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105156492
189 https://doi.org/10.1038/s41598-018-28299-9
190 rdf:type schema:CreativeWork
191 sg:pub.10.1186/s13046-016-0447-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039054821
192 https://doi.org/10.1186/s13046-016-0447-3
193 rdf:type schema:CreativeWork
194 grid-institutes:grid.174567.6 schema:alternateName Department of Human Genetics, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
195 Department of Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
196 schema:name Department of Human Genetics, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
197 Department of Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
198 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...